Minimally invasive thoracic surgery without stopping aspirin
Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw Before Surgery
This study tests if it's safe for patients with early-stage lung cancer or benign lung issues to have minimally invasive surgery while still taking their low-dose aspirin.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | The Second Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Tianqiao) |
| Trial ID | NCT05511441 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety of performing routine minimally invasive thoracic surgery while patients continue their long-term use of low-dose aspirin. It focuses on patients with stage I-IIIa non-small-cell lung cancer or benign lung lesions who require surgical intervention. The study aims to determine if continuous aspirin use during the perioperative period is safe, thereby addressing a common concern among surgeons regarding aspirin management in surgical patients.
Who should consider this trial
Good fit: Ideal candidates include patients with stage I-IIIa non-small-cell lung cancer or benign lung lesions who are undergoing minimally invasive thoracic surgery and can tolerate the procedure.
Not a fit: Patients with cardio-pulmonary function that cannot tolerate surgery or those at high risk of bleeding post-operatively may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance surgical safety and outcomes for patients who rely on aspirin for cardiovascular protection.
How similar studies have performed: While the specific approach of this study is novel, similar studies have explored the management of aspirin in surgical settings, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need Minimally Invasive Thoracic Surgery; 2. VATS and robotic surgery are both permitted; 3. cardio-pulmonary function can tolerate surgery. Exclusion Criteria: 1. cardio-pulmonary function couldn't tolerate surgery; 2. high bleeding risk after the pre- operative evaluation.
Where this trial is running
Jinan, Tianqiao
- The Second Hospital Of Shandong Univercity — Jinan, Tianqiao, China (Recruiting)
Study contacts
- Study coordinator: Yunpeng Zhao
- Email: zyp_baggio@163.com
- Phone: 18766188692
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.